3SBio Valued At $350M In Go-Private Sale To CEO, PE Firm

Law360, New York (February 8, 2013, 2:38 PM EST) -- Chinese biotech firm 3SBio Inc. will go private in a sale to Decade Sunshine Ltd., a buyer group that includes the company's top-level management and private equity backers, that values the company at about $350 million, 3SBio said Friday.

Under the terms of the deal, 3SBio shareholders will receive a $2.20-per-share cash payout, or $15.40 per American Depositary Share. Each ADS represents seven ordinary shares in the company.

The offer's terms represent a 33 percent premium over the company's close on Sept. 11, the day before...
To view the full article, register now.